Based on SEC filing data. A biotech company in Salt Lake City raised $46.6M in Series B equity funding and operates with annual revenue between $25M and $100M. The company is at the growth stage with established commercial operations in the biotechnology sector.
Get notified the moment Co-Diagnostics, Inc. (CODX) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.